CASI — CASI Pharmaceuticals, Inc.

Exchange: NASDAQ • IR Tier: D

Subscribe to CASI Earnings Calendar

http://earningstracker.com/cal/CASI.ics Add to Google Calendar

Sentiment Analysis

Analyzer Overall Avg Score Avg Confidence Positive Neutral Negative Reports
finbert-finbert neutral 0.23 91% 2 6 0 8
vader neutral 0.25 15% 2 6 0 8

Earnings History

Period Date Timing Status Call Time (ET) EPS Revenue Sentiment
Q2 2025 2025-08-29 CONFIRMED $2.1 million NEUTRAL
Q1 2025 2025-05-16 CONFIRMED NEUTRAL
Q4 2024 2025-03-31 CONFIRMED $13.4 million NEUTRAL